{"id":"https://openalex.org/W7225428353","doi":"https://doi.org/10.21203/rs.3.rs-11626343/v1","title":"Utilization of and gross spending on anti-obesity GLP-1 receptor agonists in state Medicaid programs, 2021 to 2026: a brand-level analysis of State Drug Utilization Data","display_name":"Utilization of and gross spending on anti-obesity GLP-1 receptor agonists in state Medicaid programs, 2021 to 2026: a brand-level analysis of State Drug Utilization Data","publication_year":2026,"publication_date":"2026-11-06","ids":{"openalex":"https://openalex.org/W7225428353","doi":"https://doi.org/10.21203/rs.3.rs-11626343/v1"},"language":"en","primary_location":{"id":"doi:10.21203/rs.3.rs-11626343/v1","doi":"https://doi.org/10.21203/rs.3.rs-11626343/v1","is_oa":true,"landing_page_url":"https://doi.org/10.21203/rs.3.rs-11626343/v1","pdf_url":"https://www.researchsquare.com/article/rs-11626343/latest.pdf","source":{"id":"https://openalex.org/S4306525896","display_name":"Research Square","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Research Square","raw_type":"posted-content"},"volume":null,"type":"preprint","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.researchsquare.com/article/rs-11626343/latest.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5143461495","display_name":"Brian Staiger","orcid":"https://orcid.org/0009-0009-1327-0281","observed_orcids":["https://orcid.org/0009-0009-1327-0281"]},"institutions":[{"id":"https://openalex.org/I63190737","display_name":"University at Buffalo, State University of New York","ror":"https://ror.org/01y64my43","country_code":"US","type":"education","lineage":["https://openalex.org/I63190737"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Brian Staiger","raw_affiliation_strings":["University at Buffalo, State University of New York"],"raw_orcid":"https://orcid.org/0009-0009-1327-0281","affiliations":[{"raw_affiliation_string":"University at Buffalo, State University of New York","institution_ids":["https://openalex.org/I63190737"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5143461495"],"corresponding_institution_ids":["https://openalex.org/I63190737"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.9282000064849854,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.9282000064849854,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.040699999779462814,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10391","display_name":"Healthcare Policy and Management","score":0.014600000344216824,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9819999933242798},{"id":"https://openalex.org/keywords/obesity","display_name":"obesity","score":0.382999986410141},{"id":"https://openalex.org/keywords/medicaid","display_name":"Medicaid","score":0.7009999752044678},{"id":"https://openalex.org/keywords/medication-use","display_name":"medication use","score":0.6690000295639038},{"id":"https://openalex.org/keywords/wegovy","display_name":"Wegovy","score":0.6790000200271606},{"id":"https://openalex.org/keywords/saxenda","display_name":"Saxenda","score":0.9480000138282776},{"id":"https://openalex.org/keywords/liraglutide","display_name":"liraglutide","score":0.9039999842643738},{"id":"https://openalex.org/keywords/orforglipron","display_name":"orforglipron","score":0.8640000224113464},{"id":"https://openalex.org/keywords/weight-management","display_name":"weight management","score":0.546999990940094},{"id":"https://openalex.org/keywords/drug-rebates","display_name":"drug rebates","score":0.5},{"id":"https://openalex.org/keywords/cardiovascular-risk-reduction","display_name":"cardiovascular risk reduction","score":0.6309999823570251},{"id":"https://openalex.org/keywords/obstructive-sleep-apnea","display_name":"obstructive sleep apnea","score":0.9259999990463257},{"id":"https://openalex.org/keywords/steatohepatitis","display_name":"steatohepatitis","score":0.8629999756813049},{"id":"https://openalex.org/keywords/prescribing-trends","display_name":"prescribing trends","score":0.3240000009536743}],"concepts":[{"id":"https://openalex.org/C2776534028","wikidata":"https://www.wikidata.org/wiki/Q1141363","display_name":"Medicaid","level":3,"score":0.8105999827384949},{"id":"https://openalex.org/C85079727","wikidata":"https://www.wikidata.org/wiki/Q3560114","display_name":"Quarter (Canadian coin)","level":2,"score":0.7365999817848206},{"id":"https://openalex.org/C2779703844","wikidata":"https://www.wikidata.org/wiki/Q760125","display_name":"Reimbursement","level":3,"score":0.6876999735832214},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6651999950408936},{"id":"https://openalex.org/C2778858636","wikidata":"https://www.wikidata.org/wiki/Q1643563","display_name":"Prescription drug","level":3,"score":0.586899995803833},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.5591999888420105},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.4489000141620636},{"id":"https://openalex.org/C511355011","wikidata":"https://www.wikidata.org/wiki/Q12174","display_name":"Obesity","level":2,"score":0.44359999895095825},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.36880001425743103},{"id":"https://openalex.org/C186379835","wikidata":"https://www.wikidata.org/wiki/Q253276","display_name":"Mile","level":2,"score":0.3262999951839447},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.326200008392334},{"id":"https://openalex.org/C2781308992","wikidata":"https://www.wikidata.org/wiki/Q2526479","display_name":"Liraglutide","level":4,"score":0.31949999928474426},{"id":"https://openalex.org/C195487862","wikidata":"https://www.wikidata.org/wiki/Q850210","display_name":"Revenue","level":2,"score":0.3172000050544739},{"id":"https://openalex.org/C10138342","wikidata":"https://www.wikidata.org/wiki/Q43015","display_name":"Finance","level":1,"score":0.3068000078201294},{"id":"https://openalex.org/C2983635472","wikidata":"https://www.wikidata.org/wiki/Q334911","display_name":"Health insurance","level":3,"score":0.2888999879360199},{"id":"https://openalex.org/C2777935920","wikidata":"https://www.wikidata.org/wiki/Q213600","display_name":"Sleep apnea","level":2,"score":0.27309998869895935},{"id":"https://openalex.org/C162118730","wikidata":"https://www.wikidata.org/wiki/Q1128453","display_name":"Actuarial science","level":1,"score":0.26080000400543213},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.25839999318122864},{"id":"https://openalex.org/C2910723583","wikidata":"https://www.wikidata.org/wiki/Q65066344","display_name":"Drug Utilization Review","level":3,"score":0.2558000087738037},{"id":"https://openalex.org/C74909509","wikidata":"https://www.wikidata.org/wiki/Q10387","display_name":"Gerontology","level":1,"score":0.25540000200271606},{"id":"https://openalex.org/C545542383","wikidata":"https://www.wikidata.org/wiki/Q2751242","display_name":"Medical emergency","level":1,"score":0.2538999915122986},{"id":"https://openalex.org/C2986592023","wikidata":"https://www.wikidata.org/wiki/Q1802419","display_name":"State government","level":3,"score":0.25060001015663147}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.21203/rs.3.rs-11626343/v1","doi":"https://doi.org/10.21203/rs.3.rs-11626343/v1","is_oa":true,"landing_page_url":"https://doi.org/10.21203/rs.3.rs-11626343/v1","pdf_url":"https://www.researchsquare.com/article/rs-11626343/latest.pdf","source":{"id":"https://openalex.org/S4306525896","display_name":"Research Square","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Research Square","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.21203/rs.3.rs-11626343/v1","doi":"https://doi.org/10.21203/rs.3.rs-11626343/v1","is_oa":true,"landing_page_url":"https://doi.org/10.21203/rs.3.rs-11626343/v1","pdf_url":"https://www.researchsquare.com/article/rs-11626343/latest.pdf","source":{"id":"https://openalex.org/S4306525896","display_name":"Research Square","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Research Square","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225428353.pdf","grobid_xml":"https://content.openalex.org/works/W7225428353.grobid-xml"},"referenced_works_count":11,"referenced_works":["https://openalex.org/W2275737843","https://openalex.org/W4388592674","https://openalex.org/W4392801224","https://openalex.org/W4399907994","https://openalex.org/W4409963211","https://openalex.org/W4412822888","https://openalex.org/W7156230023","https://openalex.org/W7170072885","https://openalex.org/W7204119665","https://openalex.org/W7214362512","https://openalex.org/W7224081367"],"related_works":["https://openalex.org/W7214362512","https://openalex.org/W4411176145","https://openalex.org/W7224081367","https://openalex.org/W7223614734","https://openalex.org/W7000764396","https://openalex.org/W7156230023","https://openalex.org/W7165137623","https://openalex.org/W7140106042","https://openalex.org/W7204119665","https://openalex.org/W7167841306"],"abstract_inverted_index":{"Abstract":[0],"Glucagon-like":[1],"peptide-1":[2],"(GLP-1)":[3],"receptor":[4],"agonists":[5],"marketed":[6],"for":[7,29,57,60,73,91,173,212,223,294],"chronic":[8],"weight":[9],"management":[10],"are":[11],"an":[12],"optional":[13],"Medicaid":[14,76,275],"benefit":[15],"that":[16,258],"most":[17,199],"states":[18,137,168,178,222,226,257,283],"have":[19],"not":[20,143],"covered,":[21],"but":[22],"indications":[23],"approved":[24],"in":[25,149,153,175,182,193,236,245,254],"2024":[26,187],"and":[27,36,52,59,99,116,133,155,188,206,218,272],"2025":[28,215],"cardiovascular":[30,205],"risk":[31],"reduction,":[32],"obstructive":[33],"sleep":[34,207],"apnea,":[35],"steatohepatitis":[37],"fall":[38],"outside":[39],"the":[40,45,68,92,95,105,134,183,194,201,204,219,237,246,255,288],"statutory":[41],"weight-loss":[42],"exclusion.":[43],"Because":[44],"leading":[46],"molecules":[47],"carry":[48],"separate":[49],"brand":[50,89],"names":[51],"National":[53],"Drug":[54,79],"Codes":[55],"(NDCs)":[56],"obesity":[58,174,232,286],"diabetes,":[61],"molecule-level":[62],"data":[63],"cannot":[64],"isolate":[65],"use":[66,276],"of":[67,97,108,136,186,197,200,214,249,277],"obesity-indicated":[69],"products.":[70],"Using":[71],"Centers":[72],"Medicare":[74],"&":[75],"Services":[77],"State":[78],"Utilization":[80],"Data,":[81],"we":[82],"built":[83],"a":[84,292],"state":[85,265],"by":[86,88,120],"quarter":[87,107,185,196,248],"panel":[90,290],"50":[93],"states,":[94],"District":[96],"Columbia,":[98],"Puerto":[100],"Rico":[101],"from":[102,147,158],"2021":[103,150],"through":[104],"first":[106,247],"2026.":[109],"Wegovy,":[110],"Zepbound,":[111],"Saxenda,":[112],"weight-management":[113],"liraglutide":[114],"generics,":[115],"orforglipron":[117],"were":[118,124,127,142],"identified":[119],"NDC;":[121],"diabetes-indicated":[122],"brands":[123,279],"excluded.":[125],"Outcomes":[126],"prescriptions,":[128],"gross":[129,156,216],"reimbursement":[130,157,217,262],"before":[131],"rebates,":[132],"number":[135],"reporting":[138],"utilization;":[139],"suppressed":[140],"records":[141],"imputed.":[144],"Prescriptions":[145],"rose":[146],"20,449":[148],"to":[151,161,166],"3,745,987":[152],"2025,":[154,198],"$24.7":[159],"million":[160],"$4.44":[162],"billion.":[163],"Although":[164],"12":[165],"13":[167],"formally":[169],"covered":[170],"these":[171,278],"drugs":[172],"2024,":[176],"41":[177],"reported":[179,190],"Wegovy":[180],"utilization":[181,192,234],"fourth":[184,195],"44":[189],"Zepbound":[191],"increase":[202],"following":[203],"apnea":[208],"approvals.":[209],"California":[210],"accounted":[211],"47%":[213],"five":[220],"highest-spending":[221],"81%.":[224],"Where":[225],"added,":[227],"suspended,":[228],"restored,":[229],"or":[230,242],"ended":[231,259],"coverage,":[233],"moved":[235],"same":[238],"direction":[239],"within":[240],"one":[241],"two":[243],"quarters;":[244],"2026,":[250],"prescriptions":[251],"fell":[252],"80%":[253],"four":[256],"coverage.":[260],"Gross":[261],"overstates":[263],"net":[264],"cost,":[266],"which":[267],"depends":[268],"on":[269],"confidential":[270],"rebates":[271],"federal":[273],"matching.":[274],"extends":[280],"well":[281],"beyond":[282],"with":[284],"formal":[285],"coverage;":[287],"public":[289],"provides":[291],"baseline":[293],"monitoring":[295],"future":[296],"changes.":[297]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2026-11-07T00:00:00"}